Study of nasal therapy with Vrihatjivakadya Tail in the management of migraine.

To evaluate the comparative efficacy of Nasya by Vrihatjivakadya Taila prepared from Mridu Snehapaka and Madhyama Snehapaka in the management of Ardhavbhedaka w.s.r.migraine.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/10/016140

Enrollment

100

Registered

2018-10-24

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G431- Migraine with aura

Interventions

Intervention1: Nasal administration of Vrihatjivakadya Taila in the dose of 6 drops (4.5 ml)in each nostril once a day for 14 days.: Nasal administration of Vrihatjivakadya Taila in the dose of 6 drop

Eligibility

Inclusion criteria

Inclusion criteria: (1)Patients with clinical signs and symptoms of Ardhavbhedaka. (2)Patients fit for Nasya Karma.

Exclusion criteria

Exclusion criteria: (1)Patients with severe systemic disorders. (2)Patients of sinusitis, hemiplegic migraine, basilar migraine, retinal migraine and status migranosus. (3)Patients with headache due to any organic lesion and chronic systemic disease.

Design outcomes

Primary

Measure	Time frame
Improvement in MIDAS(Migraine Disability assessment Score)Timepoint: 45 days	—

Secondary

Measure	Time frame
Relief in symptoms of Ardhavbhedaka.Timepoint: 45 days	—

Countries

India

Contacts

Public ContactDr Avadhesh kumar

National Institute of Ayurveda JaipurÂ

sarveshksingh21@gmail.com8739860237

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026